Last Updated: July 27, 2026

Claims for Patent: 8,779,109

✉ Email this page to a colleague

Summary for Patent: 8,779,109

Title:	Growth hormones with prolonged in-vivo efficacy
Abstract:	The invention relates to growth hormone compounds with a protracted profile. The effect is obtained by linking an albumin binding residue via a hydrophilic spacer to growth hormone variants. Further described are methods of preparing and using such compounds. These growth hormone compounds are based on there althered profile considered particular useful in therapy.
Inventor(s):	Behrens Carsten, Johansen Nils Langeland, Andersen Henrik Sune, Noerskov-Lauritsen Leif
Assignee:	Novo Nordisk Health Care AG
Application Number:	US14132919
Patent Claims:

Details for Patent 8,779,109

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	SOGROYA	somapacitan-beco	Injection	761156	August 28, 2020	⤷ Start Trial	2033-12-18
Novo Nordisk Inc.	SOGROYA	somapacitan-beco	Injection	761156	October 01, 2021	⤷ Start Trial	2033-12-18
Novo Nordisk Inc.	SOGROYA	somapacitan-beco	Injection	761156	April 28, 2023	⤷ Start Trial	2033-12-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 8,779,109

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201205385	⤷ Start Trial
South Africa	201205386	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2011089250	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2011089255	⤷ Start Trial
United States of America	2012309944	⤷ Start Trial
United States of America	2013040883	⤷ Start Trial
United States of America	2014107324	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.